Browse Drug Recalls
14,396 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 14,396 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 14,396 FDA drug recalls, Class II.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| May 5, 2016 | 0.1 mg/mL Morphine Sulfate and 0.05% Bupivacaine HCI (Preservative Free) in 0... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 3 mcg/mL Fentanyl Citrate and 0.0625% Bupivacaine HCl (Preservative Free) in ... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 10 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl (Preservative Free) in ... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 5 mcg/mL HYDROmorphone HCl and 0.1% Bupivacaine HCl (Preservative Free) in 0.... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 0.25% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride; , Service ... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 3.5 mcg/mL Fentanyl Citrate and 0.0625%Bupivacaine HCl (Preservative Free) in... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 2 mcg/mL Fentanyl Citrate and 0.075% Bupivacaine HCl (Preservative Free) in 0... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 5 mcg/mL Fentanyl Citrate and 0.25% Bupivacaine HCl (Preservative Free) in 0.... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 8 mcg/mL HYDROmorphone HCl and 0.05% Bupivacaine HCl (Preservative Free) in 0... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 1 mcg/mL Fentanyl Citrate and 0.08% Bupivacaine HCl (Preservative Free) in 0.... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 1 mcg/mL Fentanyl Citrate and 0.1% Bupivacaine HCl (Preservative Free) in 0.9... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 1.5 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl (Preservative Free) in... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 2 mcg/mL Fentanyl Citrate and 0.08% Bupivacaine HCl (Preservative Free) in 0.... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 2 mcg/mL Fentanyl Citrate and 0.25% Bupivacaine HCl (Preservative Free) in 0.... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 2 mcg/mL Fentanyl Citrate and 0.162% Bupivacaine HCl (Preservative Free) in 0... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 2 mcg/mL Fentanyl Citrate and 0.083% Bupivacaine HCl (Preservative Free) in 0... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 5 mcg/mL Fentanyl Citrate and 0.05% Bupivacaine HCl (Preservative Free) in 0.... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 10 mcg/mL HYDROmorphone HCl and 0.0625% Bupivacaine HCl in 0.9% Sodium Chlor... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 3 mcg/mL Fentanyl Citrate and 0.1% Bupivacaine HCl (Preservative Free) in 0.9... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 2.5 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl (Preservative Free) in... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 2 mcg/mL Fentanyl Citrate and 0.06% Bupivacaine HCl (Preservative Free) in 0.... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 3 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl (Preservative Free) in 0... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 10 mcg/mL HYDROmorphone HCl and 0.0625% Bupivacaine HCl (Preservative Free) i... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 5 mcg/mL HYDROmorphone HCl and 0.075% Bupivacaine HCl (Preservative Free) in ... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 0.0625% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, a) 250 m... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 20 mcg/mL HYDROmorphone HCl and 0.06% Bupivacaine HCl (Preservative Free) in ... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 0.5% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 250 mL in 2... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 10 mcg/mL Fentanyl Citrate and 0.075% Bupivacaine HCl (Preservative Free) in ... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 2.5 mcg/mL Fentanyl Citrate and 0.0625% Bupivacaine HCl (Preservative Free) i... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 5 mcg/mL HYDROmorphone HCl and 0.0625% Bupivacaine HCl (Preservative Free) in... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 2.5 mcg/mL Fentanyl Citrate and 0.1% Bupivacaine HCl (Preservative Free) in 0... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 2.5 mcg/mL Fentanyl Citrate and 0.0312% Bupivacaine HCl (Preservative Free) i... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 2.5 mcg/mL Fentanyl Citrate and 0.15% Bupivacaine HCl (Preservative Free) in ... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 20 mcg/mL HYDROmorphone HCl and 0.075% Bupivacaine HCl (Preservative Free) in... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 10 mcg/mL HYDROmorphone HCl and 0.125% Bupivacaine HCl (Preservative Free) in... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 0.03% Bupivacaine HCl (Preservative Free) in Sodium Chloride 0.9%, 250 mL Me... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 1 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl (Preservative Free) in 0... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 5 mcg/mL Fentanyl Citrate and 0.075% Bupivacaine HCl (Preservative Free) in 0... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 6.66 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl (Preservative Free) i... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 2 mcg/mL Fentanyl Citrate and 0.15% Bupivacaine HCl (Preservative Free) in 0.... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 10 mcg/mL HYDROmorphone HCl and 0.1% Bupivacaine HCl (Preservative Free) in 0... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 2 mcg/mL Fentanyl Citrate and 0.167% Bupivacaine HCl (Preservative Free) in 0... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 4 mcg/mL Fentanyl Citrate and 0.0625% Bupivacaine HCl (Preservative Free) in ... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 0.125% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 100 mL in... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 4, 2016 | OCTREOTIDE ACETATE INJECTION, 50 mcg (base)/mL (0.05 mg/mL), 1 mL Single Dose... | Failed Impuities/Degradation Specifications | Class II | Fresenius Kabi USA, LLC |
| May 4, 2016 | OCTREOTIDE ACETATE INJECTION, 50 mcg (base)/mL (0.05 mg/mL), 1 mL Single Dose... | Failed Impuities/Degradation Specifications | Class II | Fresenius Kabi USA, LLC |
| Apr 29, 2016 | 3rd DEGREE capsules, 60-count bottles, Manufactured for: Making it A Lifesty... | Marketed without an approved NDA/ANDA - presence of undeclared sibutramine. | Class II | Making It a Lifestyle |
| Apr 28, 2016 | Sclerosol Intrapleural Aerosol (sterile talc powder), Intrapleural administra... | Defective Delivery System: Defective stem valve causes leakage of the propellant in the spray can... | Class II | Lymol Medical |
| Apr 28, 2016 | Zoloft (sertraline HCl) tablets, 100 mg*, 30 count bottles, Rx only, Distribu... | Failed Tablet/Capsule Specifications: thick tablets exceeding specifications were found. | Class II | Pfizer Inc. |
| Apr 27, 2016 | Norditropin FlexPro Somatropin (rDNA origin) injection, 30 mg/3 mL Prefilled ... | Defective Delivery System; may have a low frequency assembly fault which may result in pens block... | Class II | Novo Nordisk Inc |
Frequently Asked Questions
When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.